Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BMRN

Biomarin Pharmaceutical Inc

May 29 • 04:00PM ET

57.29

+4.55 8.63 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ALNY IONS ARWR ASND BBIO RARE INCY CRSP EXEL VRTX

| Held by: IJH VTI VB VBK VXF XBI FBT MDY IBB SPMD

Scroll to Statements

Index	-	P/E	41.80	EPS (ttm)	1.37	Insider Own	1.55%	Shs Outstand	193.27M	Perf Week	5.90%
Market Cap	11.07B	Forward P/E	8.75	EPS next Y	6.55	Insider Trans	-1.71%	Shs Float	190.29M	Perf Month	5.68%
Enterprise Value	10.30B	PEG	0.14	EPS next Q	0.95	Inst Own	100.18%	Short Float	5.97%	Perf Quarter	-7.19%
Income	268.74M	P/S	3.37	EPS this Y	171.43%	Inst Trans	1.28%	Short Ratio	5.80	Perf Half Y	1.78%
Sales	3.29B	P/B	1.78	EPS next Y	34.00%	ROA	3.42%	Short Interest	11.36M	Perf YTD	-3.60%
Book/sh	32.14	P/C	4.98	EPS next 5Y	61.58%	ROE	4.48%	52W High	66.28 -13.56%	Perf Year	-2.15%
Cash/sh	11.50	P/FCF	14.44	EPS past 3/5Y	34.05% -16.79%	ROIC	3.52%	52W Low	49.26 16.30%	Perf 3Y	-35.25%
Dividend Est.	-	EV/EBITDA	12.70	Sales past 3/5Y	16.55% 11.97%	Gross Margin	76.28%	Volatility	3.44% 3.47%	Perf 5Y	-25.89%
Dividend TTM	-	EV/Sales	3.13	EPS Y/Y TTM	-49.09%	Oper. Margin	22.40%	ATR (14)	1.91	Perf 10Y	-35.69%
Dividend Ex-Date	-	Quick Ratio	4.20	Sales Y/Y TTM	12.53%	Profit Margin	8.17%	RSI (14)	62.48	Recom	1.59
Dividend Gr. 3/5Y	- -	Current Ratio	5.81	EPS Q/Q	-43.10%	SMA20	7.81%	Beta	0.22	Target Price	87.76
Payout	0.00%	Debt/Eq	0.23	Sales Q/Q	6.28%	SMA50	5.66%	Rel Volume	2.79	Prev Close	52.74
Employees	3221	LT Debt/Eq	0.23	Earnings	May 04 AMC	SMA200	2.61%	Avg Volume	1.96M	Price	57.29
IPO	Jul 23, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.81% 1.79%	Trades		Volume	5,464,249	Change	8.63%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)